MGI Tech reported third-quarter 2026 revenue of 783.7 million yuan ($117.6 million), up 2 percent from 771.0 million yuan in Q3 2025, according to a company report filed Oct. 24 with the Shanghai Stock Exchange. The report did not provide a revenue segment breakdown.
The net loss for the quarter was 29.5 million yuan, compared to a loss of 51.1 million yuan a year ago. The China-based sequencing and lab automation company attributed the improvement to higher revenue and gross margins, a reduction in operating costs, and increased reagent revenue as a proportion of total sales.
R&D expenses fell 11 percent in Q3 2026 to 134.7 million yuan from 152.0 million yuan in Q3 2025.
As of Sept. 30, MGI Tech held 2.84 billion yuan in cash and cash equivalents.